Alan B. Sandler Files Form 144 to Sell 331 Shares of Revolution Medicines ($RVMD)
Revolution Medicines, Inc.
Subscribe to track RVMD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📋 Form 144 Notice of Proposed Sale Issuer: Revolution Medicines, Inc. ($RVMD) Insider: Alan B. Sandler (Officer) Proposed Sale: 331 Common Stock (~$67,447.87) Approx. Sale Date: 09/15/2026 Broker: ETRADE Financial Corporation Source: RSU Vesting (09/15/2026)
Comprehensive Analysis
Executive Summary
On September 15, 2026, Alan B. Sandler, an Officer at Revolution Medicines, Inc. ($RVMD), submitted a Form 144 filing declaring the intention to sell 331 shares of common stock through ETRADE Financial Corporation, valued at approximately $67,447.87.
Transaction Details
- Filing Date: September 15, 2026
- Approximate Sale Date: September 15, 2026
- Securities Acquired: 331 shares via RSU vesting on September 15, 2026
- Aggregate Market Value: $67,447.87 (~$203.77 per share)
- Shares Outstanding: 214,336,418 shares
Impact & Significance
This transaction represents a Low market significance due to the small volume of shares (331 units), representing a negligible fraction of the company's 214.3M total shares outstanding. The shares were acquired upon RSU vesting on the same date, indicating routine equity compensation management or sell-to-cover tax obligations.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.